These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. ZTTA, a prolyl endopeptidase inhibitor, potentiates the arginine-vasopressin-induced incorporation of [14C]leucine in rat amygdaloid and cortical slices. Shishido Y; Tanaka T; Tanabe S; Furushiro M; Hashimoto S; Yokokura T; Shibata S; Watanabe S Pharm Res; 1999 Mar; 16(3):463-5. PubMed ID: 10213381 [No Abstract] [Full Text] [Related]
10. Prolyl endopeptidase: inhibition in vivo by N-benzyloxycarbonyl-prolyl-prolinal. Friedman TC; Orlowski M; Wilk S J Neurochem; 1984 Jan; 42(1):237-41. PubMed ID: 6358414 [TBL] [Abstract][Full Text] [Related]
11. Effect of ZTTA, a prolyl endopeptidase inhibitor, on memory impairment in a passive avoidance test of rats with basal forebrain lesions. Shishido Y; Furushiro M; Tanabe S; Taniguchi A; Hashimoto S; Yokokura T; Shibata S; Yamamoto T; Watanabe S Pharm Res; 1998 Dec; 15(12):1907-10. PubMed ID: 9892477 [No Abstract] [Full Text] [Related]
12. Effect of prolyl endopeptidase inhibition on arginine-vasopressin and thyrotrophin-releasing hormone catabolism in the rat brain. Bellemère G; Vaudry H; Morain P; Jégou S J Neuroendocrinol; 2005 May; 17(5):306-13. PubMed ID: 15869566 [TBL] [Abstract][Full Text] [Related]
13. Specific inhibitors of pyroglutamyl peptidase I and prolyl endopeptidase do not change the in vitro release of TRH or its content in rodent brain. Charli JL; Mendez M; Joseph-Bravo P; Wilk S Neuropeptides; 1987; 9(4):373-8. PubMed ID: 2886950 [TBL] [Abstract][Full Text] [Related]
14. [Comparative effect of the prolyl endopeptidase inhibitors, benzyloxycarbonyl-prolyl-prolinal and benzyloxycarbonyl-methionyl-cyanopyrrolidine, on the acute exudative inflammation and visceral pain in mice]. Ivanova EA; Zolotov NN; Voronina TA Biomed Khim; 2020 Sep; 66(5):423-426. PubMed ID: 33140738 [TBL] [Abstract][Full Text] [Related]
15. New potent prolyl endopeptidase inhibitors: synthesis and structure-activity relationships of indan and tetralin derivatives and their analogues. Tanaka Y; Niwa S; Nishioka H; Yamanaka T; Torizuka M; Yoshinaga K; Kobayashi N; Ikeda Y; Arai H J Med Chem; 1994 Jun; 37(13):2071-8. PubMed ID: 8027988 [TBL] [Abstract][Full Text] [Related]
16. Studies of substrate requirements, kinetic properties, and competive inhibitors of the enzymes catabolizing TRH in rat brain. Busby WH; Youngblood WW; Kizer JS Brain Res; 1982 Jun; 242(2):261-70. PubMed ID: 6126250 [TBL] [Abstract][Full Text] [Related]
17. Z-321, a prolyl endopeptidase inhibitor, augments the potentiation of synaptic transmission in rat hippocampal slices. Miura N; Shibata S; Watanabe S Behav Brain Res; 1997 Feb; 83(1-2):213-6. PubMed ID: 9062687 [TBL] [Abstract][Full Text] [Related]
18. Long-lasting enhancement of synaptic excitability of CA1/subiculum neurons of the rat ventral hippocampus by vasopressin and vasopressin(4-8). Chepkova AN; French P; De Wied D; Ontskul AH; Ramakers GM; Skrebitski VG; Gispen WH; Urban IJ Brain Res; 1995 Dec; 701(1-2):255-66. PubMed ID: 8925289 [TBL] [Abstract][Full Text] [Related]
19. The effect of inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase on TRH degradation in rat serum. Friedman TC; Wilk S Biochem Biophys Res Commun; 1985 Oct; 132(2):787-94. PubMed ID: 2865955 [TBL] [Abstract][Full Text] [Related]
20. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain. Toide K; Fujiwara T; Iwamoto Y; Shinoda M; Okamiya K; Kato T Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):355-62. PubMed ID: 8692293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]